SIGY · Sigyn Therapeutics, Inc. · Suppliers & Customers
$0.03
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“The Company had an accumulated deficit of $17,379,978 at September 30, 2025, had a working capital deficit of $3,903,920 at September 30, 2025, had net losses of $578,503 and $2,698,254, and $1,196,923 and $2,817,394 for the three and nine months ended September 30, 2025 and 2024, respectively, and net cash used in operating activities of $646,208 and $582,218 for the nine months ended September 30, 2025 and 2024, respectively, with no revenue earned since inception, and a lack of operational history. These matters raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Nov 14, 2025
Market Cap
$44,951
Shares
1.61M
Volume · Nov 6
2000
Avg daily vol (3M)
22.72K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Supply Chain
Customers, suppliers, competitors and partners, private companies included: the ones SIGY names, and the companies that name SIGY.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who SIGY sells to, buys from and competes with
- 1 supplier
- 0 customers
- 0 competitors
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.